Trospium Chloride Tablet, Film Coated
Product Images NDC 23155-530

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 23155-530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 01

Chemical structure of Trospium Chloride depicted with a bicyclic ring containing nitrogen, linked to aromatic rings and a hydroxyl group, along with a chloride ion shown separately.*

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 02

A line graph showing plasma concentration (ng/mL) over time (hours post-dose) of Trospium Chloride. The graph plots plasma concentration changes from 0 to 48 hours post-dose, including error bars indicating variability at each time point.*

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 03

A line graph comparing mean change (± SE) over 12 weeks of treatment between placebo and Trospium Chloride groups. The x-axis represents weeks of treatment (1, 4, 12), and the y-axis shows mean change values. Data points for placebo (open circles) and Trospium Chloride (filled circles) include p-values indicating statistical significance at weeks 1, 4, and 12.*

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 04

Line graph showing the mean change over time in a clinical study comparing Trospium Chloride to placebo. The x-axis is labeled Week of Treatment (1, 4, 12) and the y-axis Mean (± SE) Change, decreasing from 0 to -18. Two lines represent placebo (open circles) and Trospium Chloride (solid circles) with sample sizes listed. Statistical p-values are noted at weeks 1, 4, and 12.*

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 05

A line graph comparing the mean (± SE) change in response over weeks of treatment between placebo and Trospium Chloride groups. The x-axis represents the week of treatment (1, 4, and 12), and the y-axis shows the mean change. Trospium Chloride shows a greater mean decrease over time compared to placebo, with significance indicated by p-values at weeks 1, 4, and 12.*

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 06

A line graph comparing mean change (±SE) over weeks of treatment between Trospium Chloride and placebo groups. The x-axis shows weeks 1, 4, and 12, while the y-axis indicates mean change values. Two lines represent placebo (open circles) and Trospium Chloride (filled circles) with sample sizes of 325 and 323, respectively. Statistical significance (p<0.001) is indicated at each time point for Trospium Chloride versus placebo.*

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 07

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 08

FDA Label Image

Bf13cc11 83d9 43c1 9604 005aaba70123 09

Trospium Chloride Tablets, USP 20 mg film-coated tablets packaging label. The label specifies the tablet strength as 20 mg and contains 60 tablets per bottle. It includes instructions for pharmacists to dispense with patient information leaflets. The labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label also displays a barcode and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.